Citation: Pj. Hesketh et al., METHODOLOGY OF ANTIEMETIC TRIALS - RESPONSE ASSESSMENT, EVALUATION OFNEW AGENTS AND DEFINITION OF CHEMOTHERAPY EMETOGENICITY, Supportive care in cancer, 6(3), 1998, pp. 221-227
Authors:
GANDARA DR
ROILA F
WARR D
EDELMAN MJ
PEREZ EA
GRALLA RJ
Citation: Dr. Gandara et al., CONSENSUS PROPOSAL FOR 5HT(3) ANTAGONISTS IN THE PREVENTION OF ACUTE EMESIS RELATED TO HIGHLY EMETOGENIC CHEMOTHERAPY - DOSE, SCHEDULE, ANDROUTE OF ADMINISTRATION, Supportive care in cancer, 6(3), 1998, pp. 237-243
Authors:
ROILA F
DELFAVERO A
GRALLA RJ
TONATO M
AAPRO MS
ANDREWS PLR
BALLATORI E
DEMULDER PHM
DICATO MA
DUBOIS A
FEYER PC
GANDARA DR
GRALLA RJ
GRALLA RJ
GROSHEN S
GRUNBERG SM
HERRSTEDT J
HESKETH PJ
JOSS RA
KRIS MG
MARTY MM
MORROW GR
NAYLOR RJ
OLVER IN
SMYTH JF
SPITZER TR
STEWART A
Citation: F. Roila et al., PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE, Annals of oncology, 9(8), 1998, pp. 811-819
Authors:
RITTER HL
GRALLA RJ
HALL SW
WADA JK
FRIEDMAN C
HAND L
FITTS D
Citation: Hl. Ritter et al., EFFICACY OF INTRAVENOUS GRANISETRON TO CONTROL NAUSEA AND VOMITING DURING MULTIPLE CYCLES OF CISPLATIN-BASED CHEMOTHERAPY, Cancer investigation, 16(2), 1998, pp. 87-93
Authors:
GRALLA RJ
NAVARI RM
HESKETH PJ
POPOVIC W
STRUPP J
NOY J
EINHORN L
ETTINGER D
BUSHNELL W
FRIEDMAN C
Citation: Rj. Gralla et al., SINGLE-DOSE ORAL GRANISETRON HAS EQUIVALENT ANTIEMETIC EFFICACY TO INTRAVENOUS ONDANSETRON FOR HIGHLY EMETOGENIC CISPLATIN-BASED CHEMOTHERAPY, Journal of clinical oncology, 16(4), 1998, pp. 1568-1573
Citation: Rj. Gralla et Pa. Grusenmeyer, COMPARING THE COSTS AND COST-EFFECTIVENESS OF NEW CHEMOTHERAPY REGIMENS FOR TREATING NONSMALL CELL LUNG-CANCER (NSCLC), European journal of cancer, 33, 1997, pp. 26-26
Authors:
GRUSENMEYER PA
GRALLA RJ
TRAPANI MM
BATEMAN NM
Citation: Pa. Grusenmeyer et al., COST CONSIDERATIONS IN ALTERNATIVES TO INPATIENT CARE IN THE ADMINISTRATION OF CHEMOTHERAPY AND SUPPORTIVE CARE, European journal of cancer, 33, 1997, pp. 28-28
Authors:
BALLATORI E
ROILA F
DEANGELIS V
CICCARESE G
PALLADINO MA
TONATO M
DELFAVERO A
HERRSTEDT J
DICATO M
DUBOIS A
HESKETH P
KRIS M
GRALLA RJ
Citation: E. Ballatori et al., CLINICAL AND METHODOLOGICAL ISSUES IN ANTIEMETIC THERAPY - A WORLDWIDE SURVEY OF EXPERTS OPINIONS, Supportive care in cancer, 5(4), 1997, pp. 269-273
Authors:
PEREZ EA
NAVARI RM
KAPLAN HG
GRALLA RJ
GRUNBERG SM
PALMER RH
FITTS D
Citation: Ea. Perez et al., EFFICACY AND SAFETY OF DIFFERENT DOSES OF GRANISETRON FOR THE PROPHYLAXIS OF CISPLATIN-INDUCED EMESIS, Supportive care in cancer, 5(1), 1997, pp. 31-37
Citation: Pj. Hollen et al., A DILEMMA IN ANALYSIS - ISSUES IN THE SERIAL MEASUREMENT OF QUALITY-OF-LIFE IN PATIENTS WITH ADVANCED LUNG-CANCER, Lung cancer, 18(2), 1997, pp. 119-136
Authors:
RUBENSTEIN EB
GRALLA RJ
HAINSWORTH JD
HESKETH PJ
GROTE TH
MODIANO MR
KHOJASTEH A
KALMAN LA
BENEDICT CR
HAHNE WF
Citation: Eb. Rubenstein et al., RANDOMIZED, DOUBLE-BLIND, DOSE-RESPONSE TRIAL ACROSS 4 ORAL DOSES OF DOLASETRON FOR THE PREVENTION OF ACUTE EMESIS AFTER MODERATELY EMETOGENIC CHEMOTHERAPY, Cancer, 79(6), 1997, pp. 1216-1224
Authors:
CRAWFORD J
CHANG AY
GRALLA RJ
SOUQUET PJ
VOKES EE
Citation: J. Crawford et al., COMBINATION REGIMENS AND DOSE INTENSIFICATION IN NON-SMALL-CELL LUNG-CANCER - A PANEL DISCUSSION .1., Seminars in oncology, 23(2), 1996, pp. 22-24
Citation: Pj. Hollen et Rj. Gralla, COMPARISON OF INSTRUMENTS FOR MEASURING QUALITY-OF-LIFE IN PATIENTS WITH LUNG-CANCER, Seminars in oncology, 23(2), 1996, pp. 31-40
Authors:
CRAWFORD J
DUCH DS
GRALLA RJ
HILLNER BE
HOLLEN PJ
VOKES EE
Citation: J. Crawford et al., PHARMACOECONOMICS, QUALITY-OF-LIFE, AND COMBINATION MODALITIES IN NON-SMALL-CELL LUNG-CANCER - A PANEL DISCUSSION .2., Seminars in oncology, 23(2), 1996, pp. 53-55
Authors:
GRALLA RJ
RITTENBERG C
PERALTA M
LETTOW L
CRONIN M
Citation: Rj. Gralla et al., CISPLATIN AND EMESIS - ASPECTS OF TREATMENT AND A NEW TRIAL FOR DELAYED EMESIS USING ORAL DEXAMETHASONE PLUS ONDANSETRON BEGINNING AT 16 HOURS AFTER CISPLATIN, Oncology, 53, 1996, pp. 86-91
Authors:
KRIS MG
CUBEDDU LX
GRALLA RJ
CUPISSOL D
TYSON LB
VENKATRAMAN E
HOMESLEY HD
Citation: Mg. Kris et al., ARE MORE ANTIEMETIC TRIALS WITH A PLACEBO NECESSARY - REPORT OF PATIENT DATA FROM RANDOMIZED TRIALS OF PLACEBO ANTIEMETICS WITH CISPLATIN, Cancer, 78(10), 1996, pp. 2193-2198
Authors:
VOKES EE
ROSENBERG RK
JAHANZEB M
CRAIG JB
GRALLA RJ
BELANI CP
JONES SE
BIGLEY JW
HOHNEKER JA
Citation: Ee. Vokes et al., MULTICENTER PHASE-II STUDY OF WEEKLY ORAL VINORELBINE FOR STAGE-IV NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 13(3), 1995, pp. 637-644
Citation: Mp. Rivera et al., SYNDROME OF ACUTE DYSPNEA RELATED TO COMBINED MITOMYCIN PLUS VINCA ALKALOID CHEMOTHERAPY, American journal of clinical oncology, 18(3), 1995, pp. 245-250
Authors:
KRIS MG
PISTERS KMW
GINSBERG RJ
RIGAS JR
MILLER VA
GRANT SC
GRALLA RJ
HEELAN RT
MARTINI N
Citation: Mg. Kris et al., EFFECTIVENESS AND TOXICITY OF PREOPERATIVE THERAPY IN STAGE IIIA NONSMALL CELL LUNG-CANCER INCLUDING THE MEMORIAL SLOAN-KETTERING EXPERIENCE WITH INDUCTION MVP IN PATIENTS WITH BULKY MEDIASTINAL LYMPH-NODE METASTASES (CLINICAL N2), Lung cancer, 12, 1995, pp. 47-57
Authors:
CLERI LB
KRIS MG
TYSON LB
PISTERS KMW
CLARK RA
GRALLA RJ
Citation: Lb. Cleri et al., ORAL COMBINATION ANTIEMETICS IN PATIENTS WITH SMALL-CELL LUNG-CANCER RECEIVING CISPLATIN OR CYCLOPHOSPHAMIDE PLUS DOXORUBICIN, Cancer, 76(5), 1995, pp. 774-778